RE: Evaluation of endpoint PCR (EPCR) as a central laboratory based diagnostic test technology for SARS-3 Feb 2021 16:18
Could be. But then I am wondering what space will be left after they switch to ePCR.
Are they going to scrap all the Taqpath devices or are sales of Novacyt test going to continue for pillar 1?